TGFB1 and idiopathic pulmonary fibrosis: Consistent with this finding, rosiglitazone treatment significantly attenuated TGFβ1-mediated up-regulation of ACTA2 and COL1A1. These results demonstrate that TGFβ1 in IPF functions by reinforcing the myogenic phenotype.